YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway. The gene discussed is HDAC2; the disease is nonpapillary renal cell carcinoma.